AAMU
AGN

Amundi Asset Management US’s Allergan Inc AGN Stock Holding History

Amundi Asset Management US’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-887,293
Closed -$189M – 658
2014
Q4 		$189M Buy
887,293
+48,553
+6% +$9.65M 0.68% 33
2014
Q3 		$149M Buy
838,740
+34,111
+4% +$5.67M 0.56% 49
2014
Q2 		$136M Sell
804,629
-59,031
-7% -$9.19M 0.52% 60
2014
Q1 		$107M Buy
863,660
+43,857
+5% +$5.34M 0.41% 75
2013
Q4 		$91.1M Sell
819,803
-35,869
-4% -$3.43M 0.35% 89
2013
Q3 		$77.4M Sell
855,672
-364,889
-30% -$32.8M 0.31% 95
2013
Q2 		$103M Buy
+1,220,561
New +$127M 0.43% 65

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $5B AUM 26.58% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Amundi Asset Management US's AGN Position: Q1 2015 in Review

Amundi Asset Management US sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 887,293 shares — an estimated $189M sold.

Amundi Asset Management US first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $189M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Amundi Asset Management US reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Amundi Asset Management US sold 887,293 Allergan Inc shares in Q1 2015, an estimated $189M.
  • Amundi Asset Management US first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Amundi Asset Management US's Allergan Inc position peaked at $189M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Amundi Asset Management US's 13F filing for Q1 2015, filed 11 May 2015.